|
1
|
Khatibzadeh S, Farzadfar F, Oliver J,
Ezzati M and Moran A: Worldwide risk factors for heart failure: A
systematic review and pooled analysis. Int J Cardiol.
168:1186–1194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nikolaev VO, Moshkov A, Lyon AR, Miragoli
M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE and Gorelik J:
Beta2-adrenergic receptor redistribution in heart failure changes
cAMP compartmentation. Science. 327:1653–1657. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong H, Chen Q, Sun S, Yu H and Zhang Z:
Overexpression of beta(2)AR improves contractile function and
cellular survival in rabbit cardiomyocytes under chronic hypoxia.
Biochem Biophys Res Commun. 398:383–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bolger AP, Sharma R, von Haehling S,
Doehner W, Oliver B, Rauchhaus M, Coats AJ, Adcock IM and Anker SD:
Effect of interleukin-10 on the production of tumor necrosis
factor-alpha by peripheral blood mononuclear cells from patients
with chronic heart failure. Am J Cardiol. 90:384–389. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gullestad L, Aass H, Fjeld JG, Wikeby L,
Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S,
Ueland T, et al: Immunomodulating therapy with intravenous
immunoglobulin in patients with chronic heart failure. Circulation.
103:220–225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bosmann M, Grailer JJ, Zhu K, Matthay MA,
Sarma JV, Zetoune FS and Ward PA: Anti-inflammatory effects of β2
adrenergic receptor agonists in experimental acute lung injury.
FASEB J. 26:2137–2144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fragaki K, Kileztky C, Trentesaux C, Zahm
JM, Bajolet O, Johnson M and Puchelle E: Downregulation by a
long-acting beta2-adrenergic receptor agonist and corticosteroid of
Staphylococcus aureus-induced airway epithelial inflammatory
mediator production. Am J Physiol Lung Cell Mol Physiol.
291:L11–L18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Padda RS, Gkouvatsos K, Guido M, Mui J,
Vali H and Pantopoulos K: A high-fat diet modulates iron metabolism
but does not promote liver fibrosis in hemochromatotic Hjv¯/¯ mice.
Am J Physiol Gastrointest Liver Physiol. 308:G251–G261. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saghazadeh A, Gharedaghi M, Meysamie A,
Bauer S and Rezaei N: Proinflammatory and anti-inflammatory
cytokines in febrile seizures and epilepsy: Systematic review and
meta-analysis. Rev Neurosci. 25:281–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirota H, Izumi M, Hamaguchi T, Sugiyama
S, Murakami E, Kunisada K, Fujio Y, Oshima Y, Nakaoka Y and
Yamauchi-Takihara K: Circulating interleukin-6 family cytokines and
their receptors in patients with congestive heart failure. Heart
Vessels. 19:237–241. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurdi M and Booz GW: Can the protective
actions of JAK-STAT in the heart be exploited therapeutically?
Parsing the regulation of interleukin-6-type cytokine signaling. J
Cardiovasc Pharmacol. 50:126–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Padda RS, Shi Y, Lo CS, Zhang SL and Chan
JS: Angiotensin-(1-7): A novel peptide to treat hypertension and
nephropathy in diabetes? J Diabetes Metab. 6:1–6. 2015.
|
|
13
|
Fillatreau S, Sweenie CH, McGeachy MJ,
Gray D and Anderton SM: B cells regulate autoimmunity by provision
of IL-10. Nat Immunol. 3:944–950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshida T, Hanawa H, Toba K, Watanabe H,
Watanabe R, Yoshida K, Abe S, Kato K, Kodama M and Aizawa Y:
Expression of immunological molecules by cardiomyocytes and
inflammatory and interstitial cells in rat autoimmune myocarditis.
Cardiovasc Res. 68:278–288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asadullah K, Sterry W and Volk HD:
Interleukin-10 therapy - review of a new approach. Pharmacol Rev.
55:241–269. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Domínguez Rodríguez A, Abreu González P,
García González MJ and Ferrer Hita J: Association between serum
interleukin 10 level and development of heart failure in acute
myocardial infarction patients treated by primary angioplasty. Rev
Esp Cardiol. 58:626–630. 2005.(In Spanish). PubMed/NCBI
|
|
17
|
Verma SK, Krishnamurthy P, Barefield D,
Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V,
et al: Interleukin-10 treatment attenuates pressure
overload-induced hypertrophic remodeling and improves heart
function via signal transducers and activators of transcription
3-dependent inhibition of nuclear factor-κB. Circulation.
126:418–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wykretowicz A, Furmaniuk J, Smielecki J,
Deskur-Smielecka E, Szczepanik A, Banaszak A and Wysocki H: The
oxygen stress index and levels of circulating interleukin-10 and
interleukin-6 in patients with chronic heart failure. Int J
Cardiol. 94:283–287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stumpf C, Lehner C, Yilmaz A, Daniel WG
and Garlichs CD: Decrease of serum levels of the anti-inflammatory
cytokine interleukin-10 in patients with advanced chronic heart
failure. Clin Sci (Lond). 105:45–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamba S and Abraham WT: Alterations in
adrenergic receptor signaling in heart failure. Heart Fail Rev.
5:7–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dorn GW II, Tepe NM, Lorenz JN, Koch WJ
and Liggett SB: Low- and high-level transgenic expression of
beta2-adrenergic receptors differentially affect cardiac
hypertrophy and function in Galphaq-overexpressing mice. Proc Natl
Acad Sci USA. 96:6400–6405. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gong H, Lv Q and Lei W: The relationship
and mechanism between the expression of myocardial cells β2-AR of
rats with heart failure and cardiac function changes. Prog Mod
Biomed. 9:1024–1027. 2009.
|
|
23
|
Mizuno K, Takahashi HK, Iwagaki H, Katsuno
G, Kamurul HA, Ohtani S, Mori S, Yoshino T, Nishibori M and Tanaka
N: Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18
and IL-12 production in monocytes. Immunol Lett. 101:168–172. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Itoh CE, Kizaki T, Hitomi Y, Hanawa T,
Kamiya S, Ookawara T, Suzuki K, Izawa T, Saitoh D, Haga S, et al:
Down-regulation of beta2-adrenergic receptor expression by exercise
training increases IL-12 production by macrophages following LPS
stimulation. Biochem Biophys Res Commun. 322:979–984. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shizukuda Y and Buttrick PM: Subtype
specific roles of beta-adrenergic receptors in apoptosis of adult
rat ventricular myocytes. J Mol Cell Cardiol. 34:823–831. 2002.
View Article : Google Scholar : PubMed/NCBI
|
